The Discounted Cash Flow (DCF) valuation of Regeneron Pharmaceuticals Inc (REGN) is 671.40 USD. With the latest stock price at 733.04 USD, the upside of Regeneron Pharmaceuticals Inc based on DCF is -8.4%.
Based on the latest price of 733.04 USD and our DCF valuation, Regeneron Pharmaceuticals Inc (REGN) is a sell. selling Regeneron stocks now will result in a potential gain of 8.4%.
| Range | Selected | |
| WACC / Discount Rate | 8.2% - 10.4% | 9.3% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 494.04 - 1,087.03 | 671.40 |
| Upside | -32.6% - 48.3% | -8.4% |